SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009139
Filing Date
2022-05-11
Accepted
2022-05-11 07:26:18
Documents
67
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tngx-20220331.htm   iXBRL 10-Q 2630482
2 EX-10.1 tngx-ex10_1.htm EX-10.1 22321
3 EX-31.1 tngx-ex31_1.htm EX-31.1 19561
4 EX-31.2 tngx-ex31_2.htm EX-31.2 19432
5 EX-32.1 tngx-ex32_1.htm EX-32.1 9475
6 EX-32.2 tngx-ex32_2.htm EX-32.2 9471
  Complete submission text file 0000950170-22-009139.txt   8640786

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tngx-20220331_lab.xml EX-101.LAB 506214
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tngx-20220331_cal.xml EX-101.CAL 40453
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tngx-20220331_def.xml EX-101.DEF 256827
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tngx-20220331.xsd EX-101.SCH 59533
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tngx-20220331_pre.xml EX-101.PRE 378153
61 EXTRACTED XBRL INSTANCE DOCUMENT tngx-20220331_htm.xml XML 1412393
Mailing Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142
Business Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39485 | Film No.: 22912070
SIC: 2834 Pharmaceutical Preparations